Search results - 6 results
P142 Review of diagnostic labels for patients with unconfirmed cystic fibrosis diagnosis using registry data
Publication Type: Scientific poster, presentation or proceeding Authors: Wanyama, S. Situma; Daneau, G.; De Wachter, E.; Dupont, L. Source: Journal of Cystic Fibrosis, Volume 22, Vienna, Austria (2023) Health Topics: Cystic fibrosis Cystische fibrose Fib ...
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
estimate incidence, describe clinical presentation and investigate factors associated with severe outcomes using multivariable analysis. RESULTS: Up to December 31, 2020, 26 countries reported information on ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
a facilitating factor for ABPA. ABPA causes a significant increase in bronchial damage. In patients with ABPA, further bronchial damage can be controlled by an increase in hospitalization days and use of IV ...
Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis.
American registry analysis in cystic fibrosis (CF) children showed less lung function decline after starting inhaled corticosteroid (ICS) use. We therefore examined the influence of ICS treatment on lung ...
The burden of cystic fibrosis in Belgium: a registry-based study
elaborate the disease burden of cystic fibrosis in Belgium. Methodology: The Belgian Cystic Fibrosis Registry provides data concerning cystic fibrosis patients in Belgium. These data are used as the primary ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
regression was used to investigate factors associated with clinical progression to severe COVID-19, using the primary outcome of hospitalisation with supplemental oxygen. RESULTS: SARS-CoV-2 was reported in ...